Reported medication errors associated with methotrexate

American Journal of Health-System Pharmacy

Volumn 61, Issue 13, 2004, Pages 1380-1384

  Moore, Thomas J ^a   Walsh, Christopher S ^a   Cohen, Michael R ^a  

^a INSTITUTE FOR SAFE MEDICATION PRACTICES   (United States)

Author keywords

Antineoplastic agents; Dispensing; Dosage; Drug administration; Drug use; Drugs, adverse reactions; Errors, medication; Methotrexate; Physicians; Prescribing; Rational therapy

Indexed keywords

METHOTREXATE; FOLIC ACID ANTAGONIST;

ADVERSE DRUG REACTION; ARTICLE; DOSE CALCULATION; DRUG DOSE REGIMEN; DRUG MONITORING; DRUG USE; MEDICATION ERROR; PRESCRIPTION; PRIORITY JOURNAL; ADULT; AGED; CLINICAL PRACTICE; DRUG ADMINISTRATION; DRUG LABELING; DRUG SURVEILLANCE PROGRAM; FEMALE; FOOD AND DRUG ADMINISTRATION; HUMAN; MALE; MIDDLE AGED; RETROSPECTIVE STUDY; STATISTICS; UNITED STATES;

ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; DRUG ADMINISTRATION SCHEDULE; DRUG LABELING; FEMALE; FOLIC ACID ANTAGONISTS; HUMANS; MALE; MEDICATION ERRORS; METHOTREXATE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; RETROSPECTIVE STUDIES; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 5144222057     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/61.13.1380     Document Type: Article

References (25)

1. Pisetsky DS, St. Clair EW. Progress in the treatment of rheumatoid arthritis. JAMA. 2001; 286:2787-90.
2. Jeffes EW III, Weinstein GD. Methotrexate and other chemotherapeutic agents used to treat psoriasis. Dermatol Clin. 1995; 13:875-90.
3. Lipscomb GH, Stovall TG, Ling FW. Nonsurgical treatment of ectopic pregnancy. N Engl J Med. 2000; 343:1325-9.
4. Saeter G, Wiebe T, Wiklund T et al. Chemotherapy in osteosarcoma. The Scandinavian Sarcoma Group experience. Acta Orthop Scand Suppl. 1999; 285(Jun):74-82.
5. Gobbi PG, Ghirardelli ML, Avanzini P et al. A variant of ProMACE-CytaBOM chemotherapy for non-Hodgkin's lymphoma with threefold higher drug dose size but identical cumulative dose intensity. A pilot study of the Italian Lymphoma Study Group (GISL). Haematologica. 2000; 85:263-8.
6. Methotrexate package insert. Morgantown, WV: Wyeth-Ayerst; 2000.
7. Baughman RP, Lower EE. A clinical approach to the use of methotrexate for sarcoidosis. Thorax. 1999; 54:742-6.
8. Kremer JM, Lee JK. The safety and efficacy of the use of methotrexate in long-term therapy for rheumatoid arthritis. Arthritis Rheum. 1986; 29:822-31.
9. Sostman HD, Matthay RA, Putman CE et al. Methotrexate-induced pneumonitis. Medicine (Baltimore). 1976; 55:371-88.
10. Methotrexate Tablets, USP. Morgantown, WV: Mylan Pharmaceuticals; 2000.
11. Sosin M, Handa S. Low dose methotrexate and bone marrow suppression. BMJ. 2003; 326:266-7.
12. Sweet JM, Holstege CP. Bone marrow failure from medication error: diagnosis by history, not biopsy. Arch Intern Med. 2001; 161:1911-2.
13. Lomaestro BM, Lesar TS, Hager TP. Errors in prescribing methotrexate. JAMA. 1992; 268:2031-2.
14. Beware of erroneous daily oral methotrexate dosing. Huntingdon Valley, PA: Institute for Safe Medication Practices; 2002 Apr 3.
15. Methotrexate overdose due to inadvertent administration daily instead of weekly. Huntingdon Valley, PA: Institute for Safe Medication Practices; 2002 Dec 3.
16. Cousins D, Calnan R. Medication error reporting systems. In: Cohen M, ed. Medication errors: causes, prevention, and risk management. Boston: Jones & Bartlett; 2000.
17. Office of Drug Safety annual report FY 2001. Rockville, MD: Food and Drug Administration; 2002 Jan.
18. Center for Drug Evaluation and Research. Guidance for industry: postmarket safety reporting for human drug and biological products including vaccines. Rockville, MD: Food and Drug Administration; 2002.
19. Center for Drug Evaluation and Research. CDER 2001 report to the nation: improving public health through human drugs. Rockville, MD: Food and Drug Administration; 2002.
20. FDA quarterly extract from adverse event reporting system. Springfield, VA: National Technical Information Service; 2001.
21. Coding principles for postmarketing adverse drug reactions. Rockville, MD: Food and Drug Administration; 2002.
22. Introductory guide: MedDRA version 5.1. Reston, VA: MedDRA Maintenance and Support Services Organization; 2002.
23. National Council for Medication Error Reporting and Prevention. What is a medication error? www.nccmerp.org/ aboutMedErrors.html (accessed 2003 Jul 28).
24. Warren JL, McBean AM, Hass SL et al. Hospitalizations with adverse events caused by digitalis therapy among elderly Medicare beneficiaries. Arch Intern Med. 1994; 154:1482-7.
25. Scott HD, Rosenbaum SE, Waters WJ et al. Rhode Island physicians' recognition and reporting of adverse drug reactions. R I Med J. 1987; 70:311-6.